...
首页> 外文期刊>The Journal of Bone and Joint Surgery. British VolumecBritish Orthopaedic Association , Australian Orthopaedic Association , Canadian Orthopaedic Association . . . [et al] >Risk factors for symptomatic deep-vein thrombosis in patients after total ankle replacement who received routine chemical thromboprophylaxis
【24h】

Risk factors for symptomatic deep-vein thrombosis in patients after total ankle replacement who received routine chemical thromboprophylaxis

机译:常规化学预防性全踝置换术后患者症状性深静脉血栓形成的危险因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to identify the incidence of post-operative symptomatic deep-vein thrombosis (DVT), as well as the risk factors for and location of DVT, in 665 patients (701 ankles) who underwent primary total ankle replacement. All patients received low-molecular-weight heparin prophylaxis. A total of 26 patients (3.9%, 26 ankles) had a symptomatic DVT, diagnosed by experienced radiologists using colour Doppler ultrasound. Most thrombi (22 patients, 84.6%) were localised distally in the operated limb. Using a logistic multiple regression model we identified obesity, a previous venous thromboembolic event and the absence of full post-operative weight-bearing as independent risk factors for developing a symptomatic DVT.The incidence of symptomatic DVT after total ankle replacement and use of low-molecular-weight heparin is comparable with that in patients undergoing total knee or hip replacement.
机译:这项研究的目的是确定665例接受全踝置换的患者(701例踝关节)的症状性深静脉血栓形成(DVT)的发生率,以及DVT的危险因素和位置。所有患者均接受了低分子量肝素的预防。共有26例患者(3.9%,26例脚踝)有症状的DVT,经有经验的放射科医生使用彩色多普勒超声诊断为DVT。大多数血栓(22例患者,占84.6%)位于手术肢体的远端。使用Logistic多元回归模型,我们将肥胖,先前的静脉血栓栓塞事件以及术后没有完全负重作为发展为症状性DVT的独立危险因素。全踝关节置换和使用低剂量的DVT后症状性DVT的发生率分子量肝素与接受全膝或髋关节置换的患者相当。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号